Polymorphism of Interleukin-6 -174 G/C (rs1800795) & the Corresponding Interleukin-6 Level As a Prognostic Marker of Cervical Cancer

Overview

Journal Indian J Med Res

Specialty General Medicine

Date 2021 Dec 2

PMID 34854425

Citations 3

Authors

Priyanka Wagh

Priyanka Kulkarni

Shilpa Kerkar

Hemant Tongaonkar

Hemangi Chaudhari

Himangi Warke

Kedar Deodhar

Bharat Rekhi

Jayanti Mania-Pramanik

Affiliations

Soon will be listed here.

Abstract

Background & Objectives: Aetiology of cervical cancer (CaCx) is multifactorial. Besides human papillomavirus (HPV) infection, many immunogenetic factors are involved in this complex process. The present study was carried out to investigate one such factor, interleukin-6 (IL-6), a central pro-inflammatory cytokine and a polymorphism at its promoter region -174 G/C (rs1800795) with CaCx.

Methods: HPV-infected women with or without CaCx were enrolled in group I and II, respectively. Another group of uninfected healthy women was also included as group III for comparison. Polymorphism in IL-6-174 G/C and IL-6 levels were analyzed by sequence-specific primer PCR (PCR-SSP) and ELISA, respectively.

Results: Groups I (n=111) and II (n=87) had significantly higher frequency of IL-6-174 GG genotype [odds ratios (OR)=3.9; P<0.001 and OR=3.2; P<0.001, respectively] as compared to group III (n=163). Furthermore, individuals with GG or GC genotypes had high IL-6 levels than those with CC genotypes. IL-6 levels were significantly (P<0.001) elevated in group I. This was also significantly high in untreated cases as compared to treated (P<0.05) ones. IL-6 levels of treated group were comparable with groups II and III.

Interpretation & Conclusions: Our results suggested a possible association of IL-6-174 GG with CaCx, which was also associated with high IL-6 levels. Decreased levels of IL-6 following treatment indicate its possible prognostic use in CaCx cases.

Citing Articles

Association of interleukin6 rs1800796 gene polymorphism and serum level with bladder cancer in Egyptian population.

Mukhlif R, Abol-Enein H, Elsaid A, Abdelkhalek M, Khatab H, Youssef M Mol Biol Rep. 2024; 51(1):815.

PMID: 39009695 DOI: 10.1007/s11033-024-09791-0.

Association of cytokine gene polymorphisms with peripheral neuropathy susceptibility in people living with HIV in Greece.

Nikolaidis I, Karakasi M, Pilalas D, Boziki M, Tsachouridou O, Kourelis A J Neurovirol. 2023; 29(5):626-639.

PMID: 37695541 DOI: 10.1007/s13365-023-01169-5.

Polymorphisms of the interleukin-6 () gene contribute to cervical cancer susceptibility in Bangladeshi women: A case-control study.

Shaswati M, Oeishy F, Mumu S, Zahid M, Hossain M, Haque M Health Sci Rep. 2023; 6(5):e1238.

PMID: 37152226 PMC: 10155201. DOI: 10.1002/hsr2.1238.

References

Shi W, Liu H, Wu D, Tang Z, Shen Y, Guo L . Stratification analysis and case-control study of relationships between interleukin-6 gene polymorphisms and cervical cancer risk in a Chinese population. Asian Pac J Cancer Prev. 2014; 15(17):7357-62. DOI: 10.7314/apjcp.2014.15.17.7357. View

Zhong H, Davis A, Ouzounova M, Carrasco R, Chen C, Breen S . A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors. Cancer Res. 2016; 76(2):480-90. DOI: 10.1158/0008-5472.CAN-15-0883. View

Mania-Pramanik J, Kerkar S, Salvi V . Bacterial vaginosis: a cause of infertility?. Int J STD AIDS. 2009; 20(11):778-81. DOI: 10.1258/ijsa.2009.009193. View

Adams V, Moll C, Schmid M, Rodrigues C, Moos R, Briner J . Detection and typing of human papillomavirus in biopsy and cytological specimens by polymerase chain reaction and restriction enzyme analysis: a method suitable for semiautomation. J Med Virol. 1996; 48(2):161-70. DOI: 10.1002/(SICI)1096-9071(199602)48:2<161::AID-JMV8>3.0.CO;2-7. View

Ranganath P, Tripathi G, Sharma R, Sankhwar S, Agrawal S . Role of non-HLA genetic variants in end-stage renal disease. Tissue Antigens. 2009; 74(2):147-55. DOI: 10.1111/j.1399-0039.2009.01276.x. View

Gangwar R, Mittal B, Mittal R . Association of interleukin-6 -174G>C promoter polymorphism with risk of cervical cancer. Int J Biol Markers. 2009; 24(1):11-6. DOI: 10.1177/172460080902400102. View

Tjiong M, van der Vange N, Ten Kate F, Ter Schegget J, Burger M, Out T . Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer. Gynecol Oncol. 1999; 73(2):285-91. DOI: 10.1006/gyno.1999.5358. View

Wang S, Hildesheim A . Chapter 5: Viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr. 2003; (31):35-40. DOI: 10.1093/oxfordjournals.jncimonographs.a003480. View

Farre D, Roset R, Huerta M, Adsuara J, Rosello L, Alba M . Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 2003; 31(13):3651-3. PMC: 169011. DOI: 10.1093/nar/gkg605. View

10.

Das D, Rai A, Chandra Kataki A, Barmon D, Deka P, Sharma J . Nested multiplex PCR based detection of human papillomavirus in cervical carcinoma patients of North- East India. Asian Pac J Cancer Prev. 2013; 14(2):785-90. DOI: 10.7314/apjcp.2013.14.2.785. View

11.

de Souza N, Brenna S, Campos F, Syrjanen K, Baracat E, Silva I . Interleukin-6 polymorphisms and the risk of cervical cancer. Int J Gynecol Cancer. 2006; 16(3):1278-82. DOI: 10.1111/j.1525-1438.2006.00521.x. View

12.

Bhanoori M, Babu K, Deenadayal M, Kennedy S, Shivaji S . The interleukin-6 -174G/C promoter polymorphism is not associated with endometriosis in South Indian women. J Soc Gynecol Investig. 2005; 12(5):365-9. DOI: 10.1016/j.jsgi.2005.03.005. View

13.

Liu T, Guo Z, Wang T, Cao Y, Huang D, Wang X . Meta-analysis of the role of IL-6 rs1800795 polymorphism in the susceptibility to prostate cancer: Evidence based on 17 studies. Medicine (Baltimore). 2017; 96(11):e6126. PMC: 5369879. DOI: 10.1097/MD.0000000000006126. View

14.

Pu X, Gu Z, Wang X . Polymorphisms of the interleukin 6 gene and additional gene-gene interaction contribute to cervical cancer susceptibility in Eastern Chinese women. Arch Gynecol Obstet. 2016; 294(6):1305-1310. DOI: 10.1007/s00404-016-4175-x. View

15.

Kerkar S, Latta S, Salvi V, Mania-Pramanik J . Human Papillomavirus infection in asymptomatic population. Sex Reprod Healthc. 2010; 2(1):7-11. DOI: 10.1016/j.srhc.2010.11.001. View

16.

Kosugi E, de Camargo-Kosugi C, Weckx L, Guerreiro-da-Silva I, Gregorio L . Interleukin-6 -174 G/C promoter polymorphism and nasal polyposis. Rhinology. 2009; 47(4):400-4. DOI: 10.4193/Rhin08.226. View

17.

Giannitrapani L, Soresi M, Giacalone A, Campagna M, Marasa M, Cervello M . IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma. OMICS. 2011; 15(3):183-6. DOI: 10.1089/omi.2010.0093. View

18.

Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin J, Humphries S . The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998; 102(7):1369-76. PMC: 508984. DOI: 10.1172/JCI2629. View

19.

Vainer N, Dehlendorff C, Johansen J . Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer. Oncotarget. 2018; 9(51):29820-29841. PMC: 6049875. DOI: 10.18632/oncotarget.25661. View

20.

Kaur G, Rapthap C, Kumar N, Kumar S, Neolia S, Mehra N . Frequency distribution of cytokine gene polymorphisms in the healthy North Indian population. Tissue Antigens. 2007; 69(2):113-20. DOI: 10.1111/j.1399-0039.2006.00740.x. View